SNDX•benzinga•
HC Wainwright & Co. Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $51
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 18, 2024 by benzinga